Introduction
============

Techniques for improving the health of post-menopausal women currently focus on reducing risk factors such as coronary heart disease, deep vein thrombosis, breast cancer and gallbladder problems, with which hormone replacement therapy (HRT) may be associated ([@B1]). Because of the potential for adverse reactions to HRT, it has been proposed that the use of phytoestrogens, plant constituents with a phenolic structure similar to estrogen, may be useful for relieving climacteric symptoms rather than HRT ([@B2]). Meta-analysis of 29 studies has shown that phytoestrogens alleviate climacteric symptoms and improve lipid profiles in post-menopausal women ([@B3]).

Aromatherapy is the therapeutic use of essential oils from plants and phytoestrogens have been found in some of the essential oils used in aromatherapy ([@B4; @B5; @B6]). Many studies have found that aromatherapy improves psychological symptoms such as anxiety, depression and mood swings, and induces more relaxed states in young and middle-aged women ([@B4],[@B7; @B8; @B9; @B10]). Several aromatic oils have been recommended as phytoestrogens because they include components related to the sex hormones ([@B4],[@B6],[@B11; @B12; @B13]). Some of these oils have similar structures and functions such as clary sage, fennel, cypress, angelica and coriander ([@B4],[@B12]). It has been proposed that geranium oil balances hormones and that rose oil strengthen uterus function ([@B4],[@B6],[@B11],[@B12]). Evening primrose is recommended as a base oil in aromatherapy for menopausal women ([@B14]). However, the therapeutic effects of aromatherapy on climacteric symptoms are not well supported by clinical studies. This study was conducted to investigate whether lavender, rose geranium, rose and jasmine oils, which are used frequently in the clinical field for improving various menopausal symptoms or are recommended as phytoestrogens, improve menopausal symptoms in climacteric women when applied with massage.

Participants and Methods
========================

Participants
------------

Sixty participants took part in the study. Participants were eligible to participate in the program if: (i) they were between 45 and 54 years old; (ii) they were able to understand the content of questionnaires and experimental schedules; (iii) their endometrial thickness was \<6 mm; (iv) they were below Class II in the Papanicolaou smear test; (v) they had no history of dysplasia or cervical cancer; (vi) they agreed to the use of aromatherapy and (vii) they had no allergy to aromatherapy in accordance with a skin test, which was done during the recruitment stage. The participants were assigned to an aromatherapy group (*n* = 30) and a wait-listed age-matched control group (*n* = 30). Eight participants (five from the experimental group and three from the control group) dropped out without completing the experimental procedure. We finally analyzed 52 participants (aromatherapy group, *n* = 25; age 49.4 ± 2.6 years, mean ± SD; and control group, *n* = 27; age 50.3 ± 2.8 years, mean ± SD). The experimental protocol was approved by the Institutional Review Board (IRB) at the University Hospital. All subjects agreed to participate in the study and signed the informed consent form of the IRB. No adverse effects occurred during the experiment and the data of all participants were available for analysis.

Menopausal Symptoms
-------------------

The outcome measures were menopausal symptoms, as obtained through Kupperman\'s 11-item menopausal index ([@B15; @B16; @B17]), before and after 8 weeks of treatment. The Kupperman index is a numerical conversion index including 11 menopausal symptoms: hot flushes (vasomotor), paresthesia, insomnia, nervousness, melancholia, vertigo, weakness, arthralgia or myalgia, headache, palpitations, and formication. The items were rated on the following four-point scale: 'none' (0), 'mild' (1), 'moderate' (2), and 'severe' (3). To calculate the Kupperman index, the symptoms were weighted as follows: hot flushes (4×), parasthesia (2×), insomnia (2×), nervousness (2×) and all other symptoms (1×). Therefore, the highest potential score was 51. The score for hot flushes was based on the number of complaints per day: mild (more than five), moderate ([@B5; @B6; @B7; @B8; @B9; @B10]) and severe (more than 10).

Interventions
-------------

### Massage and oils

Each subject in the experimental group received one 30-min aromatherapy treatment session a week for 8 weeks (eight sessions in total). The treatment was a massage with essential oils of lavender, rose geranium, rose and jasmine diluted in almond and evening primrose oil. No treatment was provided to subjects in the control group, who continued their usual daily routines. The control group was provided the aromatherapy massage therapy after the 8 weeks had expired; however, the data were not collected.

The aromatherapy massage was given to subjects in the experimental group by the same certified aromatherapist (participants did not know her personally) at the same time and on the same day each week. The treatment involved an abdominal, back and arm massage with essential oils of lavender, rose geranium, rose and jasmine in a 4:2:1:1 ratio, diluted almond (90%) and evening primrose oil (10%) at a final concentration of 3%. The massage treatment room was isolated and equipped with beds warmed by heating pads. Participants were requested to lie on a bed and rest after the abdominal massage.

### Massage method

The massage began with effleurage strokes in the shape of a flat diamond, working clockwise with a pressure of 4 on a scale of 0--10, where 0 is no pressure and 10 is crushing pressure. The left hand was placed on the right hand and both hands were placed on the lower right abdomen. The stroke went to the ribs and then across the abdomen to the lower left abdomen. A cushion was placed under the subject\'s knees to keep the abdomen relaxed. This was followed by gentle kneading at the left and right of the waist, and then stroking across the abdomen. Finally, the effleurage flat diamond stroke began again. The massage on the back and arms was done in the same way. The strokes were slow, smooth and continuous.

Statistical Analysis
--------------------

The results were analyzed using SPSS software. All outcomes were compared using the unpaired *t*-test for between-group comparisons and the paired *t*-test for comparisons between baseline and post-treatment for subjects in the experimental group.

Results
=======

The groups did not differ significantly in age, age of menarche, age at first birth, height or weight ([Table 1](#T1){ref-type="table"}). Table 1.Homogeneity test for demographic characteristics (*N* = 52)CharacteristicsAromatherapy (*n* = 25)Control (*n* = 27)*t* or U*P*Age (year)49.4 ± 2.650.3 ± 2.81.250.22Menache age (year)15.2 ± 1.315.2 ± 1.7336.0[\*](#TF1){ref-type="table-fn"}0.98First birth age (year)27.9 ± 2.027.3 ± 2.0277.5[\*](#TF1){ref-type="table-fn"}0.27Height (cm)157.5 ± 4.7157.0 ± 4.50.390.70Weight (kg)56.0 ± 6.458.3 ± 6.61.260.21Body fat (%)30.0 ± 5.231.5 ± 4.80.970.34Endometrial thickness (cm)0.53 ± 0.410.42 ± 0.29223.0[\*](#TF1){ref-type="table-fn"}0.26[^1][^2]

Subcategories of Menopausal Symptoms
------------------------------------

Across all categories of menopausal symptoms measured by the Kupperman index, the mean scores were lower in the aromatherapy group after 8 weeks of treatment, whereas most scores in the control group increased ([Fig. 1](#F1){ref-type="fig"}). There were significant intergroup differences in the amount of hot flushes, melancholia and arthralgia and myalgia (all, *P* \< 0.05). There were also significant reductions in hot flushes, paresthesia and melancholia for the aromatherapy group compared with baseline (all, *P* \< 0.05), whereas the melancholia score (*P* \< 0.05) increased significantly in the control group. Figure 1.Scores for each item in the Kupperman index at baseline and after eight weeks in the aromatherapy group (*n* = 25) and the control group (*n* = 27). \**P* \< 0.05 compared with control group.

Total Menopausal Index
----------------------

The mean baseline level of the menopausal index did not differ between the two groups (*t* = 0.72, *P* = 0.47; [Fig. 2](#F2){ref-type="fig"}). However, after 8 weeks of treatment, Kupperman index scores differed significantly between the aromatherapy group and the control group (*t* = −2.08, *P* = 0.043), with significant changes from baseline in the aromatherapy group (*t* = 2.83, *P* \< 0.01). The change in the menopausal index level was more significant in the aromatherapy group than in the control group (*t* = 3.00, *P* \< 0.005, aromatherapy: −5.44 ± 9.60, mean ± SD; control: 1.59 ± 7.25). Figure 2.Mean Kupperman index score at baseline and after 8 weeks in the aromatherapy group (*n* = 25) and the control group (*n* = 27).

Discussion
==========

In this study, subjects who received an aromatherapy massage once a week for 8 weeks showed a greater reduction in menopausal symptoms than those in the control group. More specifically, aromatherapy massage improved hot flushes, depression and pain in climacteric women.

The results of the present study suggest that aromatherapy massage may improve menopausal symptoms of climacteric women. This is in accordance with previous uncontrolled trials, which reported improvement of menopausal symptoms through aromatherapy ([@B13]). Our study also supports the proposal that several aromatic essential oils have phytoestrogen effects on menopausal symptoms in climacteric women ([@B8]). Furthermore, aromatherapy massage improved hot flushes, depression and pain in the experimental group compared with the control group. These results are consistent with previous reports of the use of essential oils in treating each of these symptoms ([@B8]).

However, we acknowledge that our study has several limitations, such as non-randomized design and the lack of an equivalent-treatment control group to estimate the superior effectiveness of aromatherapy massage. Therefore, it is not clear whether the positive effects were due to the aromatherapy, the massage or both (e.g. identical results may have been achieved by using only massage, or by using aromatherapy and massage). Further randomized studies should be carried out that include more objective measures, such as hormonal changes associated with climacteric women, to explain the possible mechanism of reduction in menopausal symptoms.
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[^1]: Values are expressed as mean ± SD.

[^2]: \*Mann--Whitney U test.
